Innate Pharma S.A. (EPA:IPH)
France · Delayed Price · Currency is EUR 1.538
+0.008 (0.52%)
Aug 3, 2026, 1:35 PM CET
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of €143.7 million as of August 3, 2026. Its market cap has decreased by -15.99% in one year.
Market Cap
143.70M
Enterprise Value
131.96M
Revenue
9.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.54
ChartMarket Cap Chart
Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 143.70M, an increase of 18,041.25%. That is a compound annual growth rate of 30.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 143.70M | -2.69% |
| Dec 31, 2025 | 147.67M | -7.67% |
| Dec 31, 2024 | 159.94M | -24.29% |
| Dec 29, 2023 | 211.24M | -19.93% |
| Dec 30, 2022 | 263.84M | -24.98% |
| Dec 31, 2021 | 351.67M | 28.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Valneva SE | 407.36M |
| Valerio Therapeutics Société anonyme | 370.09M |
| Transgene | 194.73M |
| Cellectis | 179.18M |
| Sensorion | 146.18M |
| Adocia | 77.48M |
| OSE Immunotherapeutics | 75.41M |
| ABIONYX Pharma | 65.50M |